![Eric Curtis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Curtis
Plus aucun poste en cours
Fortune : - $ au 31/05/2026
Profil
Eric L.
Curtis worked at Bayer HealthCare as Vice President & General Manager-Rare Disease from 2012 to 2014.
From 2014 to 2016, worked at Aegerion Pharmaceuticals, Inc. as President-US Commercial.
From 2018 to 2020, worked at LadRx Corp.
as President & Chief Operating Officer.
Served as President & Chief Executive Officer at Centurion BioPharma Corp.
Education includes undergraduate studies at the University of Pittsburgh and an MBA from The Pennsylvania State University, conferred in 1999.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/07/2025 | 1 ( 0% ) | 0 $ | 31/05/2026 |
Anciens postes connus de Eric Curtis
| Sociétés | Poste | Fin |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Directeur des opérations | 05/01/2026 |
| LADRX CORPORATION | President | 08/03/2020 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | 01/01/2014 |
Centurion BioPharma Corp.
 Centurion BioPharma Corp. Founded in 1949, Centurion BioPharma Corp. is a Turkish pharmaceutical and American biopharmaceutical company specializing in sterile injectable products, blood products, vaccines, biosimilars, and biotechnological treatments, with a focus on rare diseases and chronic conditions. The company is based in DE. The company operates a state-of-the-art, EU GMP-certified manufacturing facility and maintains robust in-house R&D capabilities, including advanced laboratories and a skilled scientific team developing innovative generic drugs, biosimilars, and high value-added pharmaceuticals. Centurion collaborates through joint R&D, technology transfer, and licensing agreements to expand its product portfolio and market presence both domestically and internationally, including submissions for EU and other market authorizations. The company provides pharmacovigilance services aligned with national and EU regulations to monitor drug safety and efficacy and actively combats illegal and counterfeit sales of its products. Centurion BioPharma also focuses on the development of personalized medicine for solid tumor treatment, utilizing its LADR™ (Linker Activated Drug Release) technology to deliver anti-cancer therapies that target tumors more precisely. | Directeur Général | - |
Formation de Eric Curtis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Centurion BioPharma Corp.
Centurion BioPharma Corp. Founded in 1949, Centurion BioPharma Corp. is a Turkish pharmaceutical and American biopharmaceutical company specializing in sterile injectable products, blood products, vaccines, biosimilars, and biotechnological treatments, with a focus on rare diseases and chronic conditions. The company is based in DE. The company operates a state-of-the-art, EU GMP-certified manufacturing facility and maintains robust in-house R&D capabilities, including advanced laboratories and a skilled scientific team developing innovative generic drugs, biosimilars, and high value-added pharmaceuticals. Centurion collaborates through joint R&D, technology transfer, and licensing agreements to expand its product portfolio and market presence both domestically and internationally, including submissions for EU and other market authorizations. The company provides pharmacovigilance services aligned with national and EU regulations to monitor drug safety and efficacy and actively combats illegal and counterfeit sales of its products. Centurion BioPharma also focuses on the development of personalized medicine for solid tumor treatment, utilizing its LADR™ (Linker Activated Drug Release) technology to deliver anti-cancer therapies that target tumors more precisely. |
